NASDAQ$SERA

Sera Prognostics Inc-A · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Announced financial results for the fourth quarter and full year 2022 ended December 31, 2022.

Sera Prognostics reported fourth quarter 2022 revenue of $65,000, compared to $26,000 for the same period in 2021. The net loss for the fourth quarter of 2022 was $9.7 million, compared to $12.5 million for the same quarter a year ago.

  • Announced positive top-line results from the AVERT PRETERM TRIAL.
  • Announced the publication of results from a clinical utility and cost-effectiveness modeling study, ACCORDANT.
  • Validated preeclampsia risk predictor, with results made available publicly.
  • Surpassed the required 2,800 PRIME study subject enrollment, which enables the interim look analysis by year end.

Headline financials

Total Revenue

$65K

Previous: $26K+150.0%
EPS (adj)

-$0.31

Previous: -$0.41+24.4%
Capital Expenditures

$193K

Previous: $749K-74.2%
Free Cash Flow

-$7.43M

Previous: -$9.9M+24.9%
Net Income

-$9.75M

Previous: -$12.5M+21.9%
Operating Income

-$10.4M

Previous: -$12.5M+17.0%
Gross Profit

$6K

Previous: $12K-50.0%
Cash & Equivalents

$29.9M

Previous: $58.9M-49.3%
Total Assets

$116M

Previous: $147M-20.9%
Stock-Based Comp

$1.34M

Previous: $1.11M+20.5%

Revenue & EPS history

Sera Prognostics · Revenue · Quarterly

$65K

Q4 2022+150%vs Q4 2021
Beat estimate in 3 of 15 quarters(20%)
ActualEstimate

Forward guidance

No specific forward guidance was provided in the press release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

-1.9%

Avg return

Earnings day

-3.5%

Avg return

5 days after

-3.3%

Avg return

30 days after

36%

8 / 22 earnings

Positive

+14.3%

Q3 2022

Best reaction

-11.7%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.7%-8.0%+18.1%
Q4 2025-7.7%+6.3%+20.4%
Q3 2025+1.7%+8.5%+19.0%
Q1 2025-11.7%-2.1%-35.4%
Q4 2024-5.1%-2.2%-17.9%
Q3 2024-0.3%-2.7%-3.9%
Q2 2024+0.0%-1.2%-2.2%
Q1 2024+3.3%-4.0%-13.6%
Q4 2023+3.4%+1.1%+7.7%
Q3 2023-3.2%-6.4%+130.9%
Q2 2023+0.8%-10.1%-39.9%
Q1 2023-0.8%-2.8%-13.0%
Q4 2022-10.0%-9.5%-22.3%
Q3 2022+14.3%+11.1%-4.0%
Q2 2022-4.1%-6.3%-27.3%
Q1 2022-7.6%-17.1%-32.7%
Q4 2021+3.6%+0.3%-39.3%
Q3 2021+0.3%-0.8%-8.2%
Q3 2020+0.3%-0.8%-8.2%
Q2 2021-4.8%-9.9%+0.0%
Q1 2021-4.8%-9.9%+0.0%
Q4 2020-4.8%-9.9%+0.0%
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro